Louisiana State Employees Retirement System purchased a new stake in shares of Orthofix International N.V. (NASDAQ:OFIX) during the first quarter, according to its most recent disclosure with the SEC. The fund purchased 7,300 shares of the medical device company’s stock, valued at approximately $278,000.
Other institutional investors also recently bought and sold shares of the company. Capstone Asset Management Co. bought a new position in Orthofix International N.V. during the first quarter valued at about $204,000. Highbridge Capital Management LLC purchased a new stake in Orthofix International N.V. during the fourth quarter worth approximately $1,023,000. Teachers Advisors LLC increased its position in shares of Orthofix International N.V. by 18.2% in the fourth quarter. Teachers Advisors LLC now owns 35,600 shares of the medical device company’s stock worth $1,288,000 after buying an additional 5,489 shares during the last quarter. Norges Bank bought a new position in shares of Orthofix International N.V. during the fourth quarter worth about $5,664,000. Finally, Senzar Asset Management LLC acquired a new stake in Orthofix International N.V. during the fourth quarter worth approximately $4,030,000. Institutional investors own 97.31% of the company’s stock.
Orthofix International N.V. (NASDAQ:OFIX) traded up 0.83% on Monday, hitting $45.18. The stock had a trading volume of 86,680 shares. The firm’s market cap is $815.23 million. Orthofix International N.V. has a 12-month low of $32.51 and a 12-month high of $48.25. The company’s 50 day moving average is $42.15 and its 200 day moving average is $38.40.
Orthofix International N.V. (NASDAQ:OFIX) last released its earnings results on Thursday, May 4th. The medical device company reported $0.27 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.27. The company had revenue of $102.70 million during the quarter, compared to analyst estimates of $97.17 million. Orthofix International N.V. had a positive return on equity of 10.03% and a negative net margin of 0.82%. The company’s revenue for the quarter was up 4.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.28 earnings per share. On average, equities research analysts expect that Orthofix International N.V. will post $1.53 EPS for the current fiscal year.
TRADEMARK VIOLATION WARNING: “Louisiana State Employees Retirement System Buys New Stake in Orthofix International N.V. (OFIX)” was originally reported by BBNS and is the sole property of of BBNS. If you are viewing this piece on another domain, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be read at https://baseballnewssource.com/markets/7300-shares-in-orthofix-international-nv-ofix-acquired-by-louisiana-state-employees-retirement-system-updated-updated/862909.html.
OFIX has been the subject of several research reports. Zacks Investment Research cut Orthofix International N.V. from a “hold” rating to a “sell” rating in a research report on Tuesday, May 9th. SunTrust Banks, Inc. began coverage on Orthofix International N.V. in a report on Tuesday, May 23rd. They issued a “buy” rating and a $49.00 target price for the company. Ladenburg Thalmann Financial Services assumed coverage on Orthofix International N.V. in a report on Wednesday, June 14th. They issued a “buy” rating and a $53.25 target price for the company. Finally, Langenberg & Company reaffirmed a “buy” rating and issued a $53.25 price target on shares of Orthofix International N.V. in a research note on Wednesday, June 14th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $51.13.
About Orthofix International N.V.
Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.
Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with our FREE daily email newsletter.